ROBERT SKWERER: Open Payments
NPI 1184683799 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,998 in 104 payments from 16 companies in 2025. Trend: 2023 $1,529 · 2024 $2,160 · 2025 $1,998
Food & beverage: $1,998
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $405 |
| Vanda Pharmaceuticals Inc. | 12 | $257 |
| Otsuka America Pharmaceutical, Inc. | 12 | $217 |
| Janssen Pharmaceuticals, Inc | 12 | $210 |
| Alkermes, Inc. | 7 | $157 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $126 |
| Bausch Health US, LLC | 6 | $118 |
| Indivior Inc. | 4 | $104 |
| Axsome Therapeutics, Inc. | 4 | $81 |
| E.R. Squibb & Sons, L.L.C. | 3 | $78 |
Products named: VRAYLAR, REXULTI, HETLIOZ, SPRAVATO, ARISTADA, CAPLYTA, APLENZIN, SUBLOCADE.
Industry payments across NC — which companies pay providers there.
